Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care
- 22 September 2001
- Vol. 323 (7314) , 666-669
- https://doi.org/10.1136/bmj.323.7314.666
Abstract
Objectives: To determine whether antidepressants are a risk factor for ischaemic heart disease and to compare the risk for different subgroups of antidepressants and individual antidepressants. Design: Case-control study. Setting: Nine general practices recruited from the Trent Focus Collaborative Research Network. Participants: 933 men and women with ischaemic heart disease matched by age, sex, and practice to 5516 controls. Main outcome measure: Adjusted odds ratio for ischaemic heart disease calculated by logistic regression. Results: Odds ratios for ischaemic heart disease were significantly raised for patients who had ever received a prescription for tricyclic antidepressants even after diabetes, hypertension, smoking, body mass index, and use of selective serotonin reuptake inhibitors had been adjusted for (1.56; 95% confidence interval 1.18 to 2.05). Patients who had ever taken dosulepin (dothiepin) had a significantly raised odds ratio for ischaemic heart disease after adjustment for confounding factors and use of other antidepressants (1.67, 1.17 to 2.36). There was no significant increase in the odds ratios for amitriptyline, lofepramine, and selective serotonin reuptake inhibitors in multivariate analysis. Increasing maximum doses of dosulepin were associated with increasing odds ratios for ischaemic heart disease. Similarly, there was a significant positive trend associated with increasing numbers of prescriptions of dosulepin (adjusted odds ratio 1.52 for 1 prescription, 1.39 for 2-3, and 1.96 for ≥4, PConclusion: There is good evidence for an association between dosulepin and subsequent ischaemic heart disease and for a dose-response relation. What is already known on this topic Over 45% of patients in hospital after myocardial infarction have depression Depression is an independent risk factor for increased mortality and morbidity after myocardial infarction What this study adds Patients who had ever taken dosulepin (dothiepin) had significantly increased risk of ischaemic heart disease after confounding factors had been adjusted for The association followed a dose-response relation The effect of other antidepressants was not significant after adjustment for confoundersKeywords
This publication has 16 references indexed in Scilit:
- Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/The American Journal of Medicine, 2000
- How Safe Are Serotonin Reuptake Inhibitors for Depression in Patients with Coronary Heart Disease?The American Journal of Medicine, 1997
- Depression, Psychotropic Medication, and Risk of Myocardial InfarctionCirculation, 1996
- Use of Psychotropic Drugs and Risk of Myocardial Infarction: A Case-Control Study in Finnish FarmersInternational Journal of Epidemiology, 1996
- Is the Use of Psychotropic Drugs Associated with Increased Risk of Ischemic Heart Disease?Epidemiology, 1995
- Depression and 18-Month Prognosis After Myocardial InfarctionCirculation, 1995
- Greater toxicity in overdose of dothiepin than of other tricyclic antidepressantsThe Lancet, 1994
- Post-infarction depression and incomplete recovery 6 months after acute myocardial infarctionThe Lancet, 1994
- The Nature and Course of Depression Following Myocardial InfarctionArchives of internal medicine (1960), 1989
- Statistical Methods in Cancer Research. Vol. 1: The Analysis of Case-Control StudiesPublished by JSTOR ,1981